Singular Health Secures USD$1.3 Million US Contract and Completes AU$8 Million Capital Raise.

Singular Health Group (ASX: SHG) has signed a binding USD$1.3 million contract with Provider Network Solutions (PNS) to deploy its 3DICOM technology across PNS’s Primary Care Physician network in Puerto Rico, Florida, and Texas. The deal includes 1,000 licences and an additional USD$500,000 milestone payment upon integration of AI models and a central image repository. This pilot program sets the stage for a potential nationwide rollout across 30 additional states within PNS’s extended joint venture network.

To support this expansion, SHG has successfully raised AU$8 million through a placement to institutional and high-net-worth investors. The capital will fund national deployment and product enhancements. With a total addressable market of USD$19 billion across 1.3 million U.S. primary care physicians, SHG is strategically positioned for large-scale growth. This marks a major milestone in SHG’s commercial journey, tackling critical imaging inefficiencies in the U.S. healthcare system through scalable, interoperable technology.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com